Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
EV/Core EBITDA

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 244.03-351.28111.81229.901,157.82

What is the latest EV/Core EBITDA ratio of GENPHARMASEC ?

The latest EV/Core EBITDA ratio of GENPHARMASEC is 244.03 based on Mar2023 Standalone results.
Year EV/Core EBITDA
Mar2023244.03
Mar2022-351.28
Mar2021111.81
Mar2020229.90
Mar20191,157.82

How is EV/Core EBITDA of GENPHARMASEC Trending?

Years EV/Core EBITDA % Change
Mar2023 244.03
Positive
Mar2022 -351.28
Negative
Mar2021 111.81
-51.37
Mar2020 229.9
-80.14
Mar2019 1157.82 -

Other Financial Ratios of GENPHARMASEC


Compare EV/Core EBITDA ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹122.4 Cr -3.5% 4.3% 16.2% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹4,920.7 Cr -0.9% 16.7% 79.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,317.5 Cr -0.4% -0.7% 20% Stock Analytics
KIRI INDUSTRIES ₹1,912.4 Cr -2.4% 16.2% 26.8% Stock Analytics
BODAL CHEMICALS ₹993.1 Cr -1.3% 2.6% 16.9% Stock Analytics
BHAGERIA INDUSTRIES ₹779.5 Cr -1.8% 20.5% 36.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.5%

4.3%

16.2%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses